Literature DB >> 7539037

Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.

P D Katsikis1, E S Wunderlich, C A Smith, L A Herzenberg, L A Herzenberg.   

Abstract

Apoptosis (programmed cell death) of T lymphocytes has been proposed as a mechanism which plays an important role in the pathogenesis of human immunodeficiency virus (HIV) disease. Activation of Fas (CD95) can either result in costimulation of proliferation and cytokine production or in the induction of apoptosis of T lymphocytes. This raises the possibility that Fas is involved in the observed T cell apoptosis during HIV disease. In this report we show that peripheral blood CD4+ and CD8+ T lymphocytes from HIV-infected individuals undergo apoptosis in vitro in response to antibody stimulation (cross-linking) of Fas at a much higher frequency than from uninfected controls. This anti-Fas-induced T cell apoptosis is markedly higher than spontaneous T cell apoptosis in HIV-infected individuals. Antibodies against other members of the tumor necrosis factor (TNF)/nerve growth factor receptor family such as CD27, CD30, CD40, 4-1BB, p55 TNF receptor, p75 TNF receptor, and TNF receptor-related protein did not result in any increase of T cell apoptosis above that spontaneously observed in HIV+ individuals. Anti-Fas-induced apoptosis was much higher in symptomatic HIV-infected individuals; and the magnitude of anti-Fas-induced CD4+ T cell apoptosis correlated inversely with peripheral blood CD4+ T cell absolute counts. Surface expression of Fas on T cells was also found to be higher in HIV-infected individuals. Resting and activated CD4+ and CD8+ T cells both underwent apoptosis in response to anti-Fas antibody. L-Selectin positive memory CD4+ T cells were especially susceptible to anti-Fas-induced apoptosis. These findings show that CD4+ and CD8+ T lymphocytes in HIV-infected individuals are primed in vivo to undergo apoptosis in response to Fas stimulation, suggesting that Fas signaling may be responsible for the T lymphocyte functional defects and depletion observed in HIV disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539037      PMCID: PMC2192074          DOI: 10.1084/jem.181.6.2029

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Human antigen-specific memory T cells express the homing receptor (LAM-1) necessary for lymphocyte recirculation.

Authors:  T F Tedder; T Matsuyama; D Rothstein; S F Schlossman; C Morimoto
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

2.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

3.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

4.  The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Authors:  L A Tartaglia; R F Weber; I S Figari; C Reynolds; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto; A Ishii; M Yonehara; S Yonehara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Increased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemia.

Authors:  A W Wognum; G Krystal; C J Eaves; A C Eaves; P M Lansdorp
Journal:  Blood       Date:  1992-02-01       Impact factor: 22.113

7.  Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry.

Authors:  C Dive; C D Gregory; D J Phipps; D L Evans; A E Milner; A H Wyllie
Journal:  Biochim Biophys Acta       Date:  1992-02-03

8.  The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.

Authors:  G G Singer; A K Abbas
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

9.  Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease.

Authors:  S M Schnittman; J J Greenhouse; M C Psallidopoulos; M Baseler; N P Salzman; A S Fauci; H C Lane
Journal:  Ann Intern Med       Date:  1990-09-15       Impact factor: 25.391

10.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.

Authors:  H Groux; G Torpier; D Monté; Y Mouton; A Capron; J C Ameisen
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  105 in total

1.  Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.

Authors:  Y Sasaki; Y Ami; T Nakasone; K Shinohara; E Takahashi; S Ando; K Someya; Y Suzaki; M Honda
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery.

Authors:  A E Sousa; A F Chaves; M Doroana; F Antunes; R M Victorino
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.

Authors:  C J Li; Y Ueda; B Shi; L Borodyansky; L Huang; Y Z Li; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  CD4+ T cell apoptosis induced by anti-CD4 antibodies.

Authors:  Z Zhang; Y Zhang; H Zhu; J Yang; G Shen
Journal:  J Tongji Med Univ       Date:  2000

5.  Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients.

Authors:  P M Roger; J P Breittmayer; C Arlotto; P Pugliese; C Pradier; G Bernard-Pomier; P Dellamonica; A Bernard
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

6.  Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients.

Authors:  Milena Nasi; Marcello Pinti; Roberto Bugarini; Leonarda Troiano; Enrico Lugli; Cristian Bellodi; Cristina Mussini; Vanni Borghi; Tommaso Trenti; Fiorella Balli; Roberto Esposito; Andrea Cossarizza
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

7.  Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells.

Authors:  Constantinos Petrovas; Yvonne M Mueller; Ioannis D Dimitriou; Susan R Altork; Anupam Banerjee; Peter Sklar; Karam C Mounzer; John D Altman; Peter D Katsikis
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

8.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

9.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

10.  Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.

Authors:  M Paiardini; D Galati; B Cervasi; G Cannavo; L Galluzzi; M Montroni; D Guetard; M Magnani; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.